Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours

CompletedOBSERVATIONAL
Enrollment

199

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Gastrointestinal Neuroendocrine Tumours
Trial Locations (32)

10003

Hospital San Pedro de Alcántara, Cáceres

11407

Hospital Jerez de la Frontera, Cadiz

13005

Hospital General Univ. Ciudad Real, Ciudad Real

15706

Hospital Clínico Univ. de Santiago, Santiago de Compostela

17007

ICO Girona, Girona

24001

Hospital Univ. León, León

28006

Hospital de La Princesa, Madrid

28007

Hospital Gregorio Marañón, Madrid

28034

Hospital Univ. Ramón y Cajal, Madrid

28040

Hospital Clínico San Carlos, Madrid

28222

Hospital Univ. Puerta del Hierro, Madrid

28933

Hospital Rey Juan Carlos I, Móstoles

29010

Hospital Regional Univ. Málaga, Málaga

Hospital Univ.Virgen de la Victoria, Málaga

30008

Hospital General Univ. Morales Meseguer, Murcia

31008

Complejo Hospitalario de Navarra, Pamplona

33394

Hospital Univ. de Cabueñes, Gijón

37007

Hospital Clínico Univ. Salamanca, Salamanca

40002

Hospital General de Segovia, Segovia

41013

Hospital Univ. Virgen del Rocío, Seville

46026

Hospital Univ. Fe, Valencia

47003

Hospital Clínico Univ. Valladolid, Valladolid

48960

Hospital de Galdakao, Usansolo

1099-023

Instituto Portuguès de Oncologia de Lisboa, Lisbon

4200-072

Instituto Portuguès de Oncologia do Porto, Porto

03203

Hospital General Univ. Elche, Alicante

08036

Hospital Clinico y Provincial, Barcelona

09006

Hospital Univ. Burgos, Burgos

07800

Hospital Can Mises, Ibiza Town

07120

Hospital Univ. Son Espases, Palma

07198

Hospital Son Llàtzer, Palma

08221

Hospital Univ. Mútua de Terrasa, Terrassa

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY